Log In
BCIQ
Print this Print this
 

saracatinib (AZD0530)

  Manage Alerts
Collapse Summary General Information
Company AstraZeneca plc
DescriptionDual inhibitor of Src and BCR-ABL tyrosine kinase
Molecular Target Src ; BCR-ABL tyrosine kinase (BCR-ABL)
Mechanism of ActionSrc inhibitor
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationAlzheimer's disease (AD)
Indication DetailsTreat Alzheimer's disease (AD)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

12/12/2011

0

0

0

Get a free BioCentury trial today